| mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
0.031 |
0.9 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.01 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
-0.0085 |
0.9 |
| mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
0.029 |
0.9 |
| mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |